Track the MEDIBANK PRIVATE LIMITED stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €13.2bn. The latest transaction was disclosed on 29 June 2026 (Purchase). Among the most active insiders: Michael John Wilkins. All data is openly available.
Analysts rate MEDIBANK PRIVATE LIMITED Hold (neutral), based on 10 analysts. Average price target: A$5.11.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Medibank Private Limited 是一家澳大利亚医疗服务公司,专注于健康保险。它为个人和企业提供健康保险产品。